Once-daily omeprazole for treatment and prevention of gastric ulcers in horses and foals
COMPOSITION
Omeprazole 370mg/g (equivalent to 407 mg/mL)
ACTIONS
Omeprazole is a proton-pump inhibitor and suppresses gastric acid by specific inhibition of the H+/K+ ATPase enzyme system at the secretory surface of the parietal cell. Omeprazole will block gastric acid secretion irrespective of the stimulus. Maximum acid suppression occurs after 3 - 5 days of treatment.
OMOGUARD is formulated with an oil carrier base to protect the Omeprazole from acid degradation in the stomach. On passage to the alkaline intestinal environment, the Omeprazole becomes biologically available and is rapidly absorbed into the bloodstream.
INDICATIONS
Treatment and prevention of gastric ulcers in horses and foals.
By suppressing acid production, OMOGUARD creates a more neutral gastric environment which reduces ongoing damage to the gastric mucosa and also allows improved healing of existing damage.
OMOGUARD is effective in horses under a variety of management conditions, including racing or showing, in horses and foals as young as one month of age.
Clinical signs of gastric ulceration include:
Signs in foals include:
For accurate diagnosis direct endoscopic examination of the gastric mucosa is recommended.
PRESENTATION
6-Pack: 6 x 30 mL (33 g) adjustable multidose syringe.
Each syringe provides 6 treatment doses or 24 prevention doses for a 500 kg horse.
STORAGE
Store in a dry place below 25°C (Air Conditioning).
WARNINGS
When administering to competition horses, ensure that the regulations of relevant authorities are observed. OMOGUARD can be safely administered to foals from one month of age and to stallions used for breeding. Safety in pregnant or lactating mares has not been established.
Meat Withholding Period: NOT TO BE USED in horses that may be slaughtered for human consumption.
COMPOSITION
Omeprazole 370mg/g (equivalent to 407 mg/mL)
ACTIONS
Omeprazole is a proton-pump inhibitor and suppresses gastric acid by specific inhibition of the H+/K+ ATPase enzyme system at the secretory surface of the parietal cell. Omeprazole will block gastric acid secretion irrespective of the stimulus. Maximum acid suppression occurs after 3 - 5 days of treatment.
OMOGUARD is formulated with an oil carrier base to protect the Omeprazole from acid degradation in the stomach. On passage to the alkaline intestinal environment, the Omeprazole becomes biologically available and is rapidly absorbed into the bloodstream.
INDICATIONS
Treatment and prevention of gastric ulcers in horses and foals.
By suppressing acid production, OMOGUARD creates a more neutral gastric environment which reduces ongoing damage to the gastric mucosa and also allows improved healing of existing damage.
OMOGUARD is effective in horses under a variety of management conditions, including racing or showing, in horses and foals as young as one month of age.
Clinical signs of gastric ulceration include:
- depressed appetite or inappetence
- recurrent colic
- intermittent loose faeces
- chronic diarrhea
- poor hair coat
- poor body condition or poor performance
Signs in foals include:
- depressed appetite or inappetence
- teeth grinding
- dribbling saliva
- diarrhea
- sternal recumbency or weakness
For accurate diagnosis direct endoscopic examination of the gastric mucosa is recommended.
PRESENTATION
6-Pack: 6 x 30 mL (33 g) adjustable multidose syringe.
Each syringe provides 6 treatment doses or 24 prevention doses for a 500 kg horse.
STORAGE
Store in a dry place below 25°C (Air Conditioning).
WARNINGS
When administering to competition horses, ensure that the regulations of relevant authorities are observed. OMOGUARD can be safely administered to foals from one month of age and to stallions used for breeding. Safety in pregnant or lactating mares has not been established.
Meat Withholding Period: NOT TO BE USED in horses that may be slaughtered for human consumption.
- [Zebravet_Files]:
- [Zebravet_Files]